首页 › 基金 › Rhenman & Partners Asset Management AB › NRIX
Rhenman & Partners Asset Management AB 对 NRIX 的持仓历史
NURIX THERAPEUTICS INC · 医疗保健
Rhenman & Partners Asset Management AB 在 Q3 2026 的 13F 申报中披露持有 NRIX(NURIX THERAPEUTICS INC)439,500 股,市值约 US$10.4M,约占其申报组合的 1.15%,在其申报持仓中市值排名第 36 位。 Rhenman & Partners Asset Management AB 最近 10 个申报季度中有 10 个季度披露了 NRIX 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Rhenman & Partners Asset Management AB 对 NRIX 的持仓演变
Rhenman & Partners Asset Management AB 于 Q2 2024 首次披露 NRIX 持仓:174,393 股(约 US$3.6M)。 该持仓在 Q2 2026 达到峰值 684,250 股,市值约 US$16.6M。 在 10 次申报中,Rhenman & Partners Asset Management AB 4 次增持、5 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 439,500 股、市值约 US$10.4M,环比减持 -244,750 股。。 持仓曾出现大幅变动:Q3 2024 增持约 72% (随后一个季度股价下跌 16%)、Q3 2025 增持约 88% (随后一个季度股价上涨 105%)、Q2 2026 增持约 118% (随后一个季度股价下跌 2%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 174.39K | $3.64M | 新进 |
| Q3 2024 | 300.00K | $6.74M | 增持 |
| Q4 2024 | 290.00K | $5.46M | 减持 |
| Q1 2025 | 249.34K | $2.96M | 减持 |
| Q2 2025 | 185.00K | $2.11M | 减持 |
| Q3 2025 | 347.50K | $3.21M | 增持 |
| Q4 2025 | 537.50K | $10.20M | 增持 |
| Q1 2026 | 313.50K | $4.86M | 减持 |
| Q2 2026 | 684.25K | $16.60M | 增持 |
| Q3 2026 | 439.50K | $10.42M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 NRIX 与 13F 数据
NRIX(NURIX THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 45 只申报持有 NRIX,申报仓位最大的包括:Vestal Point Capital, LP (US$195.3M), Deep Track Capital, LP (US$187.7M), Rubric Capital Management LP (US$175.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 NRIX 的基金
- Vestal Point Capital, LP 8.05M 股 · $195.29M · Q2 2026
- Deep Track Capital, LP 7.74M 股 · $187.69M · Q2 2026
- Rubric Capital Management LP 7.23M 股 · $175.35M · Q2 2026
- BAKER BROS. ADVISORS LP 4.66M 股 · $113.02M · Q2 2026
- PERCEPTIVE ADVISORS LLC 4.32M 股 · $104.81M · Q2 2026
- Redmile Group, LLC 4.07M 股 · $98.83M · Q2 2026
- GENERAL ATLANTIC, L.P. 3.03M 股 · $73.56M · Q2 2026
- Trails Edge Capital Partners, LP 1.57M 股 · $38.17M · Q2 2026
- Soleus Capital Management, L.P. 1.47M 股 · $35.54M · Q2 2026
- BRAIDWELL LP 1.29M 股 · $31.22M · Q2 2026
- Kynam Capital Management, LP 1.19M 股 · $28.98M · Q2 2026
- Affinity Asset Advisors, LLC 967.62K 股 · $23.47M · Q2 2026
更多关于 Rhenman & Partners Asset Management AB
常见问题
How long has Rhenman & Partners Asset Management AB held NRIX?
Rhenman & Partners Asset Management AB has disclosed NRIX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Rhenman & Partners Asset Management AB's current position in NRIX?
As of Q3 2026, Rhenman & Partners Asset Management AB holds 439.50K shares of NRIX (NURIX THERAPEUTICS INC), valued at $10.42M, representing 1.15% of its reported portfolio and ranking #36.
Has Rhenman & Partners Asset Management AB been buying or selling NRIX?
In the latest 13F filing (Q3 2026), Rhenman & Partners Asset Management AB reduced its position in NRIX. The position peaked in Q2 2026 at 684.25K shares.
Which other funds hold NRIX?
Other major institutional holders of NRIX include Vestal Point Capital, LP, Deep Track Capital, LP, Rubric Capital Management LP, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.